Pulmonary wedge resection for clinical stage I non-small cell lung cancer: a review of a mini-invasive treatment
نویسندگان
چکیده
1General Thoracic Surgery, Hoshigaoka Medical Center, Osaka 873-8511, Japan. 2First Department of Surgery, Hamamatsu Medical University School of Medicine, Shizuoka 431-3192, Japan. 3Department of Respiratory Surgery Saitama Cardiovascular and Respiratory Center, Saitama 360-0105, Japan. 4Department of Thoracic and Cardiovascular Surgery, Nara Medical University, Nara 634-8522, Japan. 5Department of Surgery, Teikyo University School of Medicine, Tokyo 173-8605, Japan.
منابع مشابه
Analysis of the Results of Pulmonary Resection by Minimally Invasive Thoracoscopy for the Surgical Treatment of Lung Cancer
Introduction: Lung cancer is the disease of modern era, and the rate of lung cancer mortality is three times as high as that for prostate cancer and twice as high as the rate for breast cancer. We aimed to analyze the results of pulmonary resection in patients with NSCLC by minimally invasive thoracoscopy. Materials and Methods: We studied 10 patients with NSCLC scheduled for surgical resectio...
متن کاملHistory of limited resection for non-small cell lung cancer.
A retrospective study of limited resection for lung cancer in a large number of patients was first reported in the 1970s. The reported outcome of segmentectomy was comparable to that of standard lobectomy. The North American Lung Cancer Study Group (LCSG) performed a randomized controlled clinical trial to compare limited resection (segment or wedge) with lobectomy for T1N0 (stage IA) non-small...
متن کاملPrognostic value of various metabolic parameters on pre-treatment 18-F-FDG PET/CT in patients with stage I-III non-small cell lung cancer
Background: the aim of this study was to investigate the prognostic value of 18Fluorine-fluorodeoxyglucose positron emission tomography/computed tomography (18F-FDG PET/CT) parameters in both overall survival and progression-free survival in Stage I-III non-small cell lung cancer (NSCLC). Materials and Methods: In this retrospective study, 267 patients who were diagnosed as Stage I-III non-smal...
متن کاملTreatment of stage I non-small cell lung carcinoma.
The American Joint Committee on Cancer defines stage I non-small cell lung carcinoma (NSCLC) as consisting of patients with a T1 or T2 primary tumor designation and no evidence of hilar or mediastinal nodal disease (N0) or metastatic spread (M0). Medically fit patients in this clinical stage category based on conventional staging techniques should be considered for aggressive local therapy, and...
متن کاملSurvival and Prognostic Factors in Small Cell Lung Cancer Patients in Turkey
Background: Small cell lung cancer (SCLC) is a highly aggressive tumor. Objective: To evaluate the survival and time to progression of patients with SCLC admitted to a chest disease center in Istanbul, Turkey. Methods: Based on the reports of a pulmonary oncology clinic, data regarding performance status (PS), clinical stage of disease, treatment, time to progression and survival of 67 patients...
متن کامل